2022
DOI: 10.3390/mi13050706
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Paper-Based Blood Plasma Separation Device as a Potential Tool for Timely Detection of Protein Biomarkers

Abstract: A current challenge regarding microfluidic paper-based analytical devices (µPAD) for blood plasma separation (BPS) and electrochemical immunodetection of protein biomarkers is how to achieve a µPAD that yields enough plasma to retain the biomarker for affinity biosensing in a functionalized electrode system. This paper describes the development of a BPS µPAD to detect and quantify the S100B biomarker from peripheral whole blood. The device uses NaCl functionalized VF2 filter paper as a sample collection pad, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…There will be developed interest in the development of new microfluidic devices, optimization of blood separation methods, and integration with other analytical techniques. In addition, the literature indicates that much remains to be explored in this area, including the scalability of microfluidic devices, reproducibility of results, and translation of this technology into clinical settings [9].…”
Section: Type Of Microfluidics Methodsmentioning
confidence: 99%
“…There will be developed interest in the development of new microfluidic devices, optimization of blood separation methods, and integration with other analytical techniques. In addition, the literature indicates that much remains to be explored in this area, including the scalability of microfluidic devices, reproducibility of results, and translation of this technology into clinical settings [9].…”
Section: Type Of Microfluidics Methodsmentioning
confidence: 99%
“…This device does not require a membrane to separate the plasma from the whole blood sample and will be helpful in creating POC testing equipment that can identify analytes in small sample quantities. A BPS PAD was created by Burgos et al [ 143 ] to identify and measure the S100B biomarker in peripheral whole blood. The VF2 collecting pad, which conducts vertical and lateral plasma separation was added with the complete blood sample.…”
Section: Applicationsmentioning
confidence: 99%
“…Numerous techniques to control timing and sequence of fluid transport relied primarily on delaying fluid flow, by manipulating channel geometry [8], patterning hydrophobic barriers [9], control and sequential release through reservoirs and valves [10]. However, delaying flow might cause additional concerns of clogging, non-specific absorption and more critically higher evaporative loss and prolong assay time, posing difficulties for rapid and real-time monitoring of biofluids.…”
Section: Introductionmentioning
confidence: 99%
“…However, certain limitations of paper devices (µPADs) such as fixed pore dimensions and imprecise flow control, could have an impact on the accuracy and reproducibility of certain assays, restricting their utility for on-field testing [6],[7]. Numerous techniques to control timing and sequence of fluid transport relied primarily on delaying fluid flow, by manipulating channel geometry [8], patterning hydrophobic barriers [9], control and sequential release through reservoirs and valves [10]. However, delaying flow might cause additional concerns of clogging, non-specific absorption and more critically higher evaporative loss and prolong assay time, posing difficulties for rapid and real-time monitoring of biofluids.…”
Section: Introductionmentioning
confidence: 99%